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Purpose: The aim of the present study was to evaluate the feasibility and efﬁcacy of laparoscopic ventral
hernia repair under spinal anesthesia in obese patients (BMI > 30 kg/m2).
Methods: From January 2007 to February 2010, 23 obese patients had their elective laparoscopic ventral
hernia repair under spinal anesthesia. We looked primarily for intra-operative incidences as well as
immediate postoperative complications. Long term results and especially recurrences were also to be
evaluated.
Results: Median operative time was 55 min (range 20e100). Intraoperatively, six patients (26%) com-
plained of shoulder pain, three patients (13%) developed bradycardia and two (8.7%) hypotension.
Postoperatively, nausea and/or vomiting were recorded in four patients (17.4%), four patients (17.4%)
experienced urinary retention and one patient developed wound infection. Median pain score at 4th, 8th
and 24th postoperative hour was 0.5 (0e5), 1.5 (0e6), and 1.5 (0e5) respectively. The median length of
hospital stay was one day (1e2). At a median follow up of 39 months, one patient was diagnosed with a
recurrence.
Conclusion: Spinal anesthesia for LVHR in obese patients (BMI > 30 kg/m2) proved an efﬁcient and safe
alternative to general anesthesia in the given patient sample.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Ventral hernia, both primary and incisional, represents a
frequent clinical problem with both open and laparoscopic tech-
niques being used for its repair. Traditionally, the open repair is
considered, and not unfairly, as a rather challenging procedure
associated with signiﬁcant morbidity.1,2 On top of that, studies raise
the incidence of recurrence after “simple” repair up to 49%, a ﬁgure
that however seems to be limited (under 10%) when a prosthetic
mesh is used.3,4 Laparoscopic ventral hernia repair (LVHR) aimed to
offer the advantages of minimally invasive surgery in a patient
population by deﬁnition prone to postoperative complications.5,6
Traditionally, obesity has been considered a risk factor for the
formation and the repair failure as well rendering obese ventral
hernia patients, a rather “explosive” combination, poor candidates
for repair. The associated co-morbidities and the increased risk ofSZ Edinburgh, UK. Tel.: þ44
nidis).
ciates Ltd. Published by Elsevier Ltpostoperative wound infection observed in this patient population
virtually diminish the possibilities of an uneventful post-repair
recovery.1 Although general is the anesthetic of choice for laparo-
scopic procedures, the safety and efﬁcacy of performing certain
operative procedures such as cholecystectomy, transabdominal
preperitoneal inguinal hernia repair (TAPP) and ventral hernia
repair laparoscopicaly under spinal anesthesia has already been
tested and reported by our team.7e9
However, at the fear of technical difﬁculties with the estab-
lishment of the pneumoperitoneum in an alert patient, the cut-off
BMI point of 30 or 35 e depending on the trial e was used. Having
in mind that ventral hernias occur commonly in overweight pa-
tients we deduced that a signiﬁcant proportion of ventral hernia
patients were ﬁnally not offered the option of having their ventral
repaired laparoscopicaly under spinal anesthesia simply due to the
concomitant obesity. Thus, in the present study we tried to expand
the use of spinal anesthesia for LVHR in patients with BMI >30 kg/
m2 as well and practically test its efﬁcacy and efﬁciency. The
theoretical basis of this concept was to transmit the beneﬁts of the
combination of a minimally invasive surgical procedure (laparo-
scopic repair) with its anesthetic counterpart (spinal anesthesia) ind. All rights reserved.
D. Symeonidis et al. / International Journal of Surgery 11 (2013) 926e929 927
ORIGINAL RESEARCHpatients at higher risk to develop complications after the “stan-
dard” approach (open repair under general anesthesia) i.e. obese
patients (BMI > 30 kg/m2).
2. Methods
Internal board approval and ethics committee permission was obtained prior to
the initiation of this prospective study. From January 2007, all ASA I-III class I
(BMI > 30 kg/m2), class II (BMI 30e35 kg/m2) and class III (BMI > 35 kg/m2) obese
patients, undergoing elective LVHR at the University Hospital of Larissa were offered
the option of having their operation performed under spinal anesthesia irrespective
of the patients’ demographics or the characteristics of the hernia. Table 1. Patients
were encouraged to adopt a voluntary low-calorie intake diet combinedwith regular
exercise in the preoperative setting but however, none of the patients was enrolled
into a formal intensive preoperative weight loss program. In addition, when
appropriate, the option of a deﬁnite obesity surgery was discussed. Nevertheless,
none of the eligible patients opted for a simultaneous weight loss operation.
Written informed consent was obtained from every patient after the preoper-
ative anesthetic evaluation. Prospectively collected patient’s data included age,
gender, BMI, ASA status, associated co-morbidities, type of hernia and previous
operations. All procedures were performed under the same surgical and anesthetic
principles by the same relevant teams and techniques previously described.9
Regarding spinal anesthesia, with the patient in the right lateral decubitus posi-
tion, a 25-gauge pencil-point spinal needle was introduced into the subarachnoid
space at the L2eL3 intervertebral space, under aseptic conditions. After free ﬂow of
cerebrospinal ﬂuid was obtained, 3 ml of hyperbaric bupivacaine 0.5%, 0.25 mg of
morphine, and 20 mg of fentanyl were injected intrathecally. Dosages were ﬁxed and
common in all cases. Subsequently, the degree and extent of nerve block was
assessed with sequential neurological response tests. Table manipulations i.e.
Trendelenburgh and reverse Trendelenburgh were used appropriately to achieve
the desired extend/height of the anesthesia. Patients were continuously monitored
during the operation both clinically and hemodynamically. The experience in
regional anesthetic techniques of the anaesthesiologists’ involved in the study
practically rendered the use of auxiliary equipment for the completion of the block
such as ultrasound unnecessary. All spinal anesthetic procedures were performed in
the operating room.
After the induction of the analgesic and anesthetic effect of spinal anesthesia,
usually within 5e10 min after the completion of the anesthetic procedure, a CO2
pneumoperitoneum of a maximum pressure of 10 mm Hg was established by the
introduction of a 15 cm Veress needle. The type and the characteristics of the hernia
determined the site of the needle insertion. We used the left upper quadrant lapa-
roscopic needle entry instead of the standard umbilicus approach in those cases
with suspected peri-umbilical adhesions or when the umbilicus was obliviously
involved in the hernia. Then, an 11-mm optical trocar was introduced at the um-
bilical level, usually on the left side (depending on the site and/or size of the hernia)
as laterally as possible. Triangulation was achieved as two 5-mm trocars were
inserted, the ﬁrst 7e8 cm cephalad and the second 7e8 cm caudal to the optical
trocar.When a large incisional herniawas the case, an additional 5-mm trocar on the
opposite side facilitated mesh tacking.
After having any encountered adhesions released with both blunt and sharp
dissection the contents of the hernia were reduced with gentle traction. The peri-
toneal surface of the defect was subsequently cauterized with monopolar diathermy
or ultracision (Ethicon Endosurgery, Cincinnati, OH, USA) to minimize the inci-
dence of postoperative seroma formation. A dual-surface mesh (Dual Mesh Plus,
Gore Flagstone, AZ, USA) of the appropriate dimensions to ensure coverage of at
least 4 cm, preferably 5 cm, beyond the circumferential margin of the abdominal
wall defect was inserted through the optical trocar. The pneumoperitoneum pres-
sure was then reduced to 8 mm Hg and the mesh was secured in place using a
Protack device (USSC). Transfacial sutures were not used. No drain was used in any
of the procedures. Finally, a self-adhesive bandage was used to compress externally
the skin/subcutaneous tissue for the following 5e7 days.
We recorded the operative time, the type and size of the mesh used for the
hernia repair. Any intraoperative incidents, especially those related to the method of
anesthesia and/or the pneumoperitoneum such as changes in the cardiopulmonary
function and/or hemodynamic status, shoulder pain, discomfort, nausea, etc. were
also recorded. The patients were encouraged to ask for conversion of the anesthesia
throughout the procedure if they felt so.
demographics.Postoperative analgesia was standardized (40 mg parecoxib so-
dium twice a day iv and 500 mg paracetamol tabl every 6 h per os). AntibioticTable 1
Patient’s
Total number of patients 23
Age (mean  standard deviation) 55.3  13.5 (Range 28e75)
Gender (male:female) 10:13
BMI (kg/m2 e mean  standard deviation) 36.09  5.61 (Range 30e51)
ASA (IeIV e mean  standard deviation) 1.96  0.77 (Range 1e3)chemoprophylaxis was not routinely used and only patients who required a Foley
catheter received a single dose of a second generation cephalosporin. On the other
hand, all patients received low molecular weight heparin (Enoxaparin sodium
40 mg/daily) subcutaneously for deep vein thrombosis prophylaxis. Patients were
allowed to get mobilized late in the afternoon after the procedure; theywere given a
light diet and were discharged the next morning unless a complication had super-
vened. The Visual Analogue Scale (VAS) was used in order to assess postoperative
pain at the 4th, 8th and 24th postoperative hour. Additionally, we looked for im-
mediate postoperative complications such as seroma, hematoma, or infection.
All patients were followed 10e15 days after the operation as outpatients, in
order that early complications such as seroma, hematoma, infection as well as the
degree of patient’s satisfaction from the procedure could be assessed. Thereafter,
they were clinically assessed as outpatients 6 and 12 months postoperatively. They
were also contacted at the time of data collection for the preparation of this paper
(January 2012) by phone interview in order to update the follow-up data regarding
the long-term results, especially recurrences. When a doubt arose, a clinical ex-
amination at the outpatient clinic was scheduled.
3. Results
From January 2007 to February 2010, twenty-three (23) ASA Ie
III patients (ASA I: 7 patients, ASA II: 10 patients and ASA III: 6
patients e Male: Female: 10:13) with a BMI greater than 30 kg/m2
were included in the study. The patient’s demographics and the
concomitant morbidities present are shown in Tables 1 and 2
respectively. Regarding the type of the hernia, ten (10) patients
had primary umbilical/para-umbilical hernia, six (6) had primary
epigastric hernia, seven (7) had incisional hernia, two (2) had more
than one aponeurotic defects and ﬁnally two (2) patients were
operated due to a recurrent incisional hernia.
A laparoscopic mesh-based ventral hernia repair, as previously
described, was undertaken in all cases. The median mesh surface
area was 190 cm2 (range 80e408). No conversions were recorder
from both the anesthetic and the surgical point of view. Themedian
operative time was 55 min (range 20e100) while regarding the
technique itself no major intraoperative complications were
recorded. Intra-operatively, shoulder pain requiring intravenous
non-steroid anti-inﬂammatory drugs (NSAIDs) administration was
recorded in six (6) patients (26%), three (3) patients (13%) devel-
oped bradycardia (deﬁned as heart rate equal to or less than 50
beats/min) successfully reversed with intravenous atropine
administration, while two (2) patients (8.7%) developed hypoten-
sion (deﬁned as systolic blood pressure lower than 100 mmHg)
requiring vasoactive agent administration and ﬂuid overload.
During the immediate postoperative period, nausea and/or
vomiting were recorded in four (4) patients (17.4%) treated with
intravenous granisetron administration, while four (4) male pa-
tients (17.4%) experienced urinary retention requiring the place-
ment of a Foley catheter. None of the patients complained of
headache or other spinal related neurologic sequel. Median pain
score on the 4th, 8th and 24th postoperative hour was 0.5 (range
0e5), 1.5 (range 0e6), and 1.5 (range 0e5) respectively. The median
length of hospital stay was one (1) day (range 1e2) while no
operation related readmissions were recorded.
At 2-weeks follow up one (1) patient (4.3%) developed wound
infection ecellulitis- treated as outpatient with broad spectrum
antibiotics, while two (2) patients developed small seromas
requiring no speciﬁc treatment. Regarding the assessment of the
long term results, two patients (8.7%) were lost to follow up. During
a median follow up of 39 months (11e59 months), one (1) patient
(4.7%) with primary epigastric hernia was diagnosed clinically with
a recurrence some 12 months after the repair. No other late com-
plications were recorded.
4. Discussion
Abdominal wall hernias, both primary and incisional, represent
a challenging clinical problem. Approximately 3e10% of
Table 2
Incidence (no. of patients e %) of co-morbidities in the present patient sample.
Co-morbidities No of patients (%)
Metabolic
Type 2 diabetes mellitus 5 (21.7%)
Type 1 diabetes mellitus 1 (4.3%)
Cardiovascular
Arterial hypertension 7 (30.4%)
Ischemic heart disease 2 (8.7%)
Dysrhythmias 1 (4.3%)
Pulmonary
Chronic obstructive pulmonary disease 4 (17.4%)
Obstructive sleep apnea syndrome 1 (4.3%)
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disposing factors include age, wound infection, immunosuppres-
sion, morbid obesity, previous operation, prostatism, and surgery of
aneurismal disease.10,11 From the pathology point of view, primary
abdominal wall hernias have been associated with diseases of the
extracellular matrix.12 On the other hand, incisional hernias more
often involve a combination of both mechanical and biological
factors. Generally, laparotomy provokes defects in the process of
wound healing by substantially decreasing the extracellular matrix
synthesis.12 However, besides the changes in the molecular level,
pure mechanical causes are interfered as well. The increased
pressure on the abdominal wall seen in conditions such as the
obesity and the chronic obstructive pulmonary disease (COPD)
seems to additionally contribute in the process of hernia
formation.13
Generally, the open repair with mesh placement is the most
widely used procedure for the treatment of ventral hernias.2 By
deﬁnition, open repair requires signiﬁcant dissection of tissue
usually of poor quality as well as the creation of a cutaneous ﬂap
increasing signiﬁcantly the complication and recurrence rates.4
Aiming in communicating the advantages of minimally invasive
surgery, LVHR had been suggested from reports already in the early
90’s. Several studies evaluating the two techniques (open and
laparoscopic) suggested that the laparoscopic repair appears su-
perior to open in terms of wound complications and recurrence
rates.2,14e19 However, the limitations of the need for careful patient
selection and of the adequate expertise in endoscopic surgery are
almost commonly underlined as prerequisites for a successful
outcome.14e19
The concept of transmitting the beneﬁts of minimally invasive
surgery into a ventral hernia patient subgroup of by deﬁnition
increased perioperative morbidity such as the obese patients
seemed attractive. The co-existence e in a possible causative rela-
tion e of the two conditions (ventral hernia and obesity) is such
high that, by excluding obese patients from the laparoscopic
approach, very few patients with ventral hernias would eventually
beneﬁt from the well-established advantages of minimally invasive
surgery. Indeed, LVHR can be safely performed in obese patients.20e
23 However in this study, we aimed to take LVHR in obese patients’
one step forward.
Having proved mainly, the efﬁcacy and safety of spinal anes-
thesia for laparoscopic cholecystectomy, TAPP inguinal hernia
repair and LVHR mainly in non-obese patients,7e9 we aimed to
extend the spectrum and the beneﬁts gained from the use of spinal
anesthesia in class I,II and III obese patients undergoing ventral
hernia repair. We hypothesized that, if the combination of a mini-
mally invasive surgical technique e laparoscopic repair e with its
anesthetic equivalent e spinal anesthesia e works, then extra
beneﬁts could be seen particularly on obese patients submitted to
ventral hernia repair. The avoidance of general anesthesia along
with the avoidance of an open repair in these ventral hernia pa-
tients at least sounds as a very attractive perspective.A thin balance is encountered on the homeostasis of patients of
BMI> 30 kg/m2 summarized in the diminished pulmonary reserves
and the distressed cardiovascular system along with the increased
cardiac output.24 The physiologically increased intra-abdominal
pressure in obese patients could further complicate the ﬁeld
requiring higher insufﬂation pressures to achieve adequate expo-
sure.25 Within this framework, the pneumoperitonium-related ef-
fects such as venous stasis, reduced portal vein blood ﬂow,
decreased renal perfusion and output are augmented.25 Spinal
anesthesia could possibly makes things easier with the induced
abdominal wall muscle relaxation effect i. permitting the comple-
tion of the procedure under lower net intra-abdominal pressures ii.
achieving optimal repair conditions both for the hernia reduction
and the mesh ﬁxation using the laparoscopic tack device as well
and ultimately iii. decreasing the impact of the operative stress on
an already burdened patient.26 Although the systematic use of
agents that could depress the respiratory system i.e. opiates cannot
be precluded even during spinal anesthesia, its use is by deﬁnition
lower than in general anesthesia.
However, the limitations of regional anesthesia should be
carefully considered as well. Even though a successful regional
anesthetic allows minimal manipulation of the airway, the poten-
tial for airway compromise cannot be eliminated. In addition, the
anthropometric changes associated with obesity can make the
performance of spinal anesthesia technically difﬁcult. BMI of more
than 25 kg/m2 represents an independent risk factor for block
failure.27 Furthermore, the rate of block failure seems to increase
incrementally with BMI.27 However, the adequate expertise in
spinal anesthesia, the use of the proper instrumentation such as
longer spinal needles and, when appropriate, the utilization of ul-
trasound for delineating the anatomy of the region could overcome
the difﬁculties rendering obesity certainly not a contraindication
for spinal anesthesia.
Our team, in a previously published study, proved the feasibility
of laparoscopic ventral hernia repair under spinal anesthesia
generally in non-obese patients. However, in the present study we
tried to evaluate the feasibility and efﬁcacy of LVHR under spinal
anesthesia in patients with a BMI greater than 30 kg/m2. All pro-
cedures were successfully completed as planned with spinal as the
standalone and sole anesthetic method. No conversion of either the
anesthetic or the surgical approach was required. The minor
intraoperative incidences encountered such as hypotension (8.7%)
and bradycardia (13%) could be reasonably attributed to the normal
physiologic responses of the anesthetized spinal sympathetic nerve
ﬁbers and were easily reversed with the appropriate interventions.
As one of the main challenges in this study was to avoid using
agents that could further depress the already distressed respiratory
system especially of ASA II and III obese patients, we hopefully
managed to address complaints of intraoperative pain only with
the use of NSAIDs. We additionally recorded postoperative pa-
rameters such as immediate postoperative pain (24 h), the inci-
dence of wound infection and the length of hospital stay yielding
absolutely acceptable results.
Urinary retention, a common complication after spinal anes-
thesia, was encountered in (4) four male patients (17.3%) all with
known history of prostatism. Despite the fact that the observed
urinary retention incidence of 17.3% in the study appears reassur-
ing, the reduction of the result in the male subjects raises the uri-
nary retention incidence to 40% (4 out of 10 male patients).
Recently, we have focused our efforts in reducing this dismal
complication by altering the composition of the mixture injected
intrathecally. The reduction e if not the complete elimination e of
morphine has yield really impressive yet anecdotal results.
However, the major fear after any kind of hernia repair is
recurrence. Regarding the repair technique itself, we aimed for the
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believe that the placement of transfascial sutures would be
feasible from the anesthetic and technical point of view we used
nothing but tacks to secure the mesh in place, an approach not far
from recent literature reports.28,29 Only one patient in this series
(4.7%) was diagnosed with a recurrence some twelve months after
the operation. The observed recurrence rate validated through a
follow up period of almost ﬁve years (median 39 months) lies well
within the reported in the literature.29 Though, a longer period of
observation and a more homogeneous patient sample especially
regarding the hernia characteristics (i.e. incisional hernias, size of
hernia defect) would be ideal in order to evaluate recurrences
more accurately.30 In this study, according to the study design we
do not have any objective data regarding the size of the hernias.
However i. as the hernia characteristics was not among the in-
clusion for the study criteria and ii. because the 4e5 cm circum-
ferential abdominal wall e mesh overlap rule was adopted in all
case, an indirect indication of the median hernia defect size can be
relatively accurately extracted through the median mesh surface
area (190 m2).
However, a few things should be kept in mind before inter-
preting the results of the present study. First, the results are
expressed without the calibrating effect of a control group. Second,
the relatively small number of patients ﬁnally included in the study
renders generalizations regarding the reported incidence of the
parameters studied i.e. postoperative complications, recurrences
quite hazardous. Acknowledging the pilot nature of the study,
represent the safest way to elicit and highlight only the positive
aspects out of this report. In the present study we aimed to
establish spinal as a valid anesthetic option for this patient group.
Whether spinal is or is not superior to general anesthesia for
ventral hernia repair in obese patients is a question that requires
further well designed studies to be answered.Within this context, a
controlled randomized study of LVHR in obese patients
(BMI > 30 kg/m2) under spinal or general anesthesia is currently
designed and standardized in our department in order to provide
more solid evidences regarding the actual contribution of spinal
anesthesia on the favorable results reported in the present study.
In conclusion, spinal anesthesia for LVHR in obese patients
proved an efﬁcient and safe alternative to general anesthesia in the
given patient sample.
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